SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16618564
Source:
http://linkedlifedata.com/resource/pubmed/id/16618564
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004587
,
umls-concept:C0005682
,
umls-concept:C0007099
,
umls-concept:C0033085
,
umls-concept:C0035647
,
umls-concept:C0194401
,
umls-concept:C0205265
,
umls-concept:C1555582
pubmed:issue
4
pubmed:dateCreated
2006-4-18
pubmed:abstractText
To critically evaluate the survival of patients with high-grade Ta or T1 urothelial cancer (UC) or carcinoma in situ of the bladder who have received bacillus Calmette-Guérin (BCG) and who have undergone radical cystectomy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16618564-18219733
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0366151
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic
,
http://linkedlifedata.com/resource/pubmed/chemical/BCG Vaccine
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1527-9995
pubmed:author
pubmed-author:KimSandy SSS
,
pubmed-author:ManoharanMurugesanM
,
pubmed-author:NiederAlan MAM
,
pubmed-author:SimonMichael AMA
,
pubmed-author:SolowayMark SMS
pubmed:issnType
Electronic
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
737-41
pubmed:dateRevised
2008-2-21
pubmed:meshHeading
pubmed-meshheading:16618564-Adjuvants, Immunologic
,
pubmed-meshheading:16618564-Aged
,
pubmed-meshheading:16618564-BCG Vaccine
,
pubmed-meshheading:16618564-Carcinoma, Transitional Cell
,
pubmed-meshheading:16618564-Carcinoma in Situ
,
pubmed-meshheading:16618564-Combined Modality Therapy
,
pubmed-meshheading:16618564-Cystectomy
,
pubmed-meshheading:16618564-Female
,
pubmed-meshheading:16618564-Humans
,
pubmed-meshheading:16618564-Male
,
pubmed-meshheading:16618564-Neoplasm Staging
,
pubmed-meshheading:16618564-Retrospective Studies
,
pubmed-meshheading:16618564-Risk Factors
,
pubmed-meshheading:16618564-Urinary Bladder Neoplasms
pubmed:year
2006
pubmed:articleTitle
Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation.
pubmed:affiliation
Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33140, USA. anieder1@med.miami.edu
pubmed:publicationType
Journal Article